Metraipolis › archive › dc_5b889d323bfa

A synergistic antioxidant nanozyme platform for corneal neovascularization treatment — Europe PMC PMID:42666588

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42666588
DOI
10.1039/d6na00297h
License (as archived)
solo-consultazione
Archived
2026-10-16T15:05:06.436Z
SHA-256 of the archived text
f38ad51451cd1695a914ff3f0c091318b0d285448d9fa734351a707aaff3c68e
Stable URL of this page
https://metraipolis.com/documento/dc_5b889d323bfa

How to cite

A synergistic antioxidant nanozyme platform for corneal neovascularization treatment — Europe PMC PMID:42666588 — Europe PMC (en), https://europepmc.org/article/MED/42666588 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5b889d323bfa (Metraipolis archive dc_5b889d323bfa, sha256 f38ad51451cd1695a914ff3f0c091318b0d285448d9fa734351a707aaff3c68e)
BibTeX
@misc{dc5b889d323bfa,
  title = {A synergistic antioxidant nanozyme platform for corneal neovascularization treatment — Europe PMC PMID:42666588},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42666588},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5b889d323bfa; sha256 f38ad51451cd1695a914ff3f0c091318b0d285448d9fa734351a707aaff3c68e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42666588. Agents can read the archived copy with the MCP tool read_document.